--- schema_type: "SoftwareApplication" entity_type: "Mobile Application" app_name: "Lilly Health™" developer_entity: "Eli Lilly and Company" bundle_id: "com.lilly.android.lillyhealth" category: "Medical" primary_platform: "android" primary_monetization: "Free" offline_capable: false market_region: "US" platforms: "Android" app_last_updated: "2026-07-29" report_date: "2026-08-08" last_verified: "2026-08-08T00:00:00.000Z" report_version: "3.0.2" total_reviews: 632 overall_rating: 4.6 sentiment: "Frustrated" sentiment_score: 25 confidence: "medium" confidence_score: 0.55 top_praise_theme: "The updated visual interface feels cleaner and less clinical than previous versions for daily users" top_complaint_theme: "Frequent application crashes and freezing after the latest update prevent users from logging daily data" review_sample_size: 50 total_review_count: 50 analyzed_review_count: 50 data_age_days: 8 momentum_velocity: "maintenance" intelligence_version: 3 tags: ["medical", "free", "frustrated sentiment", "mobile app", "app review", "app analysis", "residents", "older", "currently"] canonical_url: "https://marlvel.ai/apps/lilly-health" license: "CC-BY-NC 4.0" content_version: "v2" --- ## ⚠ Content Warning This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here. --- # Lilly Health™ Intelligence Report ## TL;DR {#tldr} - **Category**: Medical · Free - **Signal**: Rating 4.57 · Sentiment Frustrated - **Recent focus**: Frequent application crashes and freezing after the latest update prevent users from logging daily data (top complaint) · The updated visual interface feels cleaner and less clinical than previous versions for daily users (top praise) > **TL;DR:** Lilly Health™ is a medical app by Eli Lilly and Company, rated 4.57/5 by 632 users, with Frustrated user sentiment (25/100), available on Android. > > **Marlvel.ai App Intelligence** - Independent analysis. US Market. No publisher influence. > **Key Insight:** Lilly Health™ faces Frustrated user sentiment (4.57/5 from 632 reviews), with users reporting frequent application crashes and freezing after the latest update prevent users from logging daily data as the primary concern. ## Quick Facts | Fact | Value | | :--- | :--- | | **Rating** | 4.57/5 (632 reviews) | | **User Mood** | Frustrated | | **Category** | Medical | | **Developer** | Eli Lilly and Company | | **Pricing** | Free | | **Platforms** | Android | | **Confidence** | Medium (0.55/1.0) | | **Data Age** | 8d | ## Metadata & Market Performance - **Publisher:** Eli Lilly and Company - **Category:** Medical - **Target Audience:** U.S. residents aged 18 and older currently prescribed Zepbound, Mounjaro, or Foundayo. - **Platforms:** Android - **Version Reviewed:** 3.0.2 - **Report Date:** 2026-08-08 - **Signal Count:** 50 reviews analyzed - **Confidence:** Medium (0.55/1.0) - **Google Play ID:** com.lilly.android.lillyhealth - **Performance Trend:** Stable - **Data Window:** Analysis based on signals collected up to 2026-08-08 - **Short Description:** Lilly Health™ gives you access to tools, tracking & support ## Executive Snapshot **What it is:** Lilly Health™ is a medical tracking app for Eli Lilly patients to manage medication, activity, and health trends on iOS and Android. **Why users hire it:** Users hire the app to maintain treatment adherence and visualize progress for their healthcare providers, reducing the friction of manual health logging. ## App DNA (Features & Intent) - **[Standard] Logbook:** Centralized tracking for medication, physical activity, and health metrics. * *User Intent:* Users want visibility into their own performance and progress. - **[Differentiator] Trend Visualization:** Charts and custom time-range reports for sharing health progress with providers. * *User Intent:* Users value self-expression and personalized experiences. - **[Standard] Dosing Reminders:** Customizable push notifications for medication schedules. * *User Intent:* Users value self-expression and personalized experiences. ## Market Position {#market-position} Lilly Health™ currently holds the #29 position in the US Medical category. The app's reliance on specific medication prescriptions limits its addressable market compared to general health trackers. ## Monetization Strategy - **Model:** Free - **Tiers:** Free for all users - **Analysis:** The app operates as a free, value-added service for patients prescribed specific Eli Lilly medications. ## 🔴 User Sentiment (Medium Confidence: 50 of 50 reviews analyzed) {#user-sentiment} - **Overall Rating:** 4.57/5 - **Platform Split:** Android 4.6/5 (632 ratings) - **Overall Sentiment:** Frustrated - **Note:** The 4.57/5 store rating reflects cumulative history, while the Frustrated sentiment reflects recent user reviews analyzed by our AI pipeline. ### Top Praises - **The updated visual interface feels cleaner and less clinical than previous versions for daily users** - **Home delivery and packaging services provide a reliable experience for patients managing their medication** ### Top Complaints (Impact Areas) - **Frequent application crashes and freezing after the latest update prevent users from logging daily data** ## SWOT Analysis {#swot} **Core Strengths:** - Direct integration with Eli Lilly treatment protocols ensures high-intent user retention **Growth Levers:** - Integration of wearable step-counting data would address the #1 user-requested feature ## Recent Changes (v2 → v3) {#recent-changes} The app's competitive narrative shifted from viewing stability issues as a brand liability to framing its medication-locked nature as a strategic retention mechanism. **Overall trend**: Stable **Compared at**: 2026-08-08 ### High-impact changes - **[Shifted] Strategic Narrative Pivot** (positioning) ### Medium-impact changes - **[Removed] SWOT Consolidation** (swot) ## What's New - **Latest (v3.0.2, 1 weeks ago):** General performance improvements. ## App Momentum (Maintenance) {#momentum} - Ships stability-focused updates. - No new feature builds. > **Cadence:** 1 total versions · 0 majors in last 6 months · 10 days since last update ## The "So What?" (Strategic Takeaway) {#so-what} Lilly Health™ is a medical app that is completely free. With a 4.57/5 rating from 632 reviews, it draws more critical themes in recent reviews than its store average suggests. > **Bottom Line:** Lilly Health™ provides a necessary bridge for medication adherence, but the recent update's instability risks alienating the core patient base, so the team must prioritize stability over new features to maintain trust. **Best for:** U.S. residents aged 18 and older currently prescribed Zepbound, Mounjaro, or Foundayo. ### PM Action Plan (Next Best Moves) - [ ] [INVEST] Stabilize the core logging engine because crashes are the #1 churn driver → restore daily active habit ### Outlook: Declining The medical tracking market is consolidating around reliable, multi-device health platforms. Lilly Health™ is currently exposed due to recent stability regressions, which will accelerate churn if not addressed before the next medication cycle. - 🔴 Frequent application crashes and data loss following the latest update erode user trust, which directly reduces the daily active habit. ## Key Metrics Summary | Metric | Value | | :--- | :--- | | Overall Rating | 4.57/5 | | Total Reviews | 632 | | Sentiment | Frustrated (25/100) | | Confidence | Medium | | Pricing Model | Free | | Platforms | Android | | Key Features | 3 analyzed | | Trend | Stable | | Outlook | Declining | ## Competitor Comparison | App | Rating | Sentiment | Developer | | :--- | :--- | :--- | :--- | | **Lilly Health™** (this app) | 4.57/5 | Frustrated | Eli Lilly and Company | | [필잇 - 약 알림 및 복용 기록](https://marlvel.ai/apps/app--35) | N/A/5 | N/A | Hansub Yoo | | [레어노트 - 암·희귀질환 정보](https://marlvel.ai/apps/app--629) | 5.0/5 | N/A | LifeX, Inc. | | [창고형약국 약값체크](https://marlvel.ai/apps/com-hiddenwave-yakcheck) | N/A/5 | N/A | Lowkeybase | | [용인세브란스병원](https://marlvel.ai/apps/com-severance-newys) | 1.9/5 | N/A | Yonsei University Health System | | [1001Doktor](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) | 4.8/5 | N/A | 1001Doktor Ltd. Şti. | ## Company Profile - **Developer:** Eli Lilly and Company ## Data Sources & Links - **Google Play:** [View on Google Play](https://play.google.com/store/apps/details?id=com.lilly.android.lillyhealth&hl=en&gl=us) - **Sources:** App store metadata, User reviews. ## Related Intel Reports - [*필잇 - 약 알림 및 복용 기록*](https://marlvel.ai/apps/app--35) (Hansub Yoo) · N/A Rating - [*레어노트 - 암·희귀질환 정보*](https://marlvel.ai/apps/app--629) (LifeX, Inc.) · 5.0/5 Rating - [*창고형약국 약값체크*](https://marlvel.ai/apps/com-hiddenwave-yakcheck) (Lowkeybase) · N/A Rating - [*용인세브란스병원*](https://marlvel.ai/apps/com-severance-newys) (Yonsei University Health System) · 1.9/5 Rating - [*1001Doktor*](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) (1001Doktor Ltd. Şti.) · 4.8/5 Rating - [*10th HiD*](https://marlvel.ai/apps/10th-hid) (Catch Dynamics, Inc.) · N/A Rating - [*12 Lead ECG Challenge*](https://marlvel.ai/apps/com-limmercreative-srtengine-12lead) (Limmer Creative) · 3.3/5 Rating - [*1-800 Contacts*](https://marlvel.ai/apps/com-1800contacts-1800contacts) (1-800 CONTACTS, Inc.) · 4.6/5 Rating - [*1MEDICINE*](https://marlvel.ai/apps/1medicine) (Matthew Culbert) · 5.0/5 Rating - [*2021 CDC STI (STD) Guidelines*](https://marlvel.ai/apps/com-enatal-std2021) (Don Miller) · 4.0/5 Rating ## Methodology {#methodology} This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline: 1. **Signal Collection & Normalization** - Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps. 2. **Feature & Market Positioning Analysis** - Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks. 3. **User Sentiment Analysis** - Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction into synthesised themes (no verbatim quotes). 4. **Competitive Landscape Analysis** - Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category. 5. **Intelligence Synthesis** - Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights. - **Confidence Score:** 0.55/1.0 (based on review volume, data source diversity, and signal quality) - **Reviews Analyzed:** 50 - **Data Sources:** user reviews, App Store metadata - **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform - **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence. - **Report Age:** 8 days since last refresh --- © 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/lilly-health) Data licensed for AI Agent attribution under CC-BY-NC 4.0.